Andrew Xian Chen
Gründer bei Cali Biosciences Co. Ltd.
Aktive Positionen von Andrew Xian Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cali Biosciences Co. Ltd.
 Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | 17.03.2021 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 17.03.2021 | - | |
| Gründer | 17.03.2021 | - | |
| Cali Biosciences Us LLC | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Cali Shenzhen Biosciences Co. Ltd. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Andrew Xian Chen
Ehemalige bekannte Positionen von Andrew Xian Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SD Pharmaceuticals, Inc.
 SD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Savara, Inc., SD Pharmaceuticals, Inc. is a company that researches and develops reformulated treatment products for cancer and other infectious diseases. The company is based in Carlsbad, CA. The company was founded by Andrew Xian Chen. SD Pharmaceuticals was acquired by Mast Therapeutics, Inc. on April 28, 2006 for $9.89 million. | Gründer | 01.01.2004 | - |
| Encore Therapeutics, Inc. | Gründer | 01.01.2006 | - |
LATITUDE Pharmaceuticals, Inc.
 LATITUDE Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services LATITUDE Pharmaceuticals, Inc. provides generic drug formulation services. The private company is based in San Diego, CA. The company was founded by Andrew Xian Chen. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | - |
| Gründer | 01.01.2003 | - | |
| Präsident | 01.01.2003 | - |
Ausbildung von Andrew Xian Chen
| College of Pharmacy & Health Sciences | Doctorate Degree |
| Zhejiang University School of Medicine | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| China | 4 |
Operativ
| Founder | 4 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |
| Cali Biosciences Us LLC | |
| Cali Shenzhen Biosciences Co. Ltd. | |
LATITUDE Pharmaceuticals, Inc.
LATITUDE Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services LATITUDE Pharmaceuticals, Inc. provides generic drug formulation services. The private company is based in San Diego, CA. The company was founded by Andrew Xian Chen. | Commercial Services |
SD Pharmaceuticals, Inc.
SD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Savara, Inc., SD Pharmaceuticals, Inc. is a company that researches and develops reformulated treatment products for cancer and other infectious diseases. The company is based in Carlsbad, CA. The company was founded by Andrew Xian Chen. SD Pharmaceuticals was acquired by Mast Therapeutics, Inc. on April 28, 2006 for $9.89 million. | Health Technology |
| Encore Therapeutics, Inc. |
- Börse
- Insiders
- Andrew Xian Chen
- Erfahrung